Please check your internet connection and try again.
# Sompraz HP (Esomeprazole HP-8)
## Overview
Sompraz HP is a combination product containing esomeprazole magnesium (a proton pump inhibitor) and amoxicillin and clarithromycin (antibiotics). It is designed for the eradication of *Helicobacter pylori* infection. Esomeprazole reduces stomach acid, creating an environment more favorable for the antibiotics to work.
## Primary Indications
* Eradication of *Helicobacter pylori* infection in patients with active peptic ulcer disease or a history of peptic ulcer disease.
## Adult Dosing
**Sompraz HP** is typically administered as a 14-day regimen. The specific dosing of each component within the Sompraz HP package should be followed as directed by the manufacturer's instructions. Generally, the regimen involves:
* Esomeprazole 20 mg capsule once daily.
* Amoxicillin 500 mg capsule twice daily.
* Clarithromycin 250 mg tablet twice daily.
**Note:** The exact number of capsules and tablets per day and their timing will depend on the specific packaging and regimen provided in the Sompraz HP kit.
## Pediatric Dosing
Data for pediatric use of Sompraz HP is limited. Standard pediatric dosing for H. pylori eradication with individual components (esomeprazole, amoxicillin, clarithromycin) should be followed as per established guidelines, which may require separate formulations.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment is typically required for esomeprazole or clarithromycin in mild to moderate renal impairment. Use with caution in severe renal impairment. Amoxicillin doses may need adjustment based on renal function per standard guidelines.
* **Hepatic Impairment:** Use with caution in severe hepatic impairment. Dose adjustments for esomeprazole may be necessary in severe liver disease.
## Contraindications
* Known hypersensitivity to esomeprazole, amoxicillin, clarithromycin, or any component of the formulation.
* History of allergic reactions to penicillins or cephalosporins.
* Concurrent use with cisapride, pimozide, quinidine, or terfenadine (due to potential for QT prolongation with clarithromycin).
* Severe hepatic insufficiency or cholestatic jaundice.
## Adverse Effects
Common adverse effects include diarrhea, nausea, abdominal pain, headache, and taste disturbances. Serious adverse effects can include severe allergic reactions (including anaphylaxis), *Clostridioides difficile*-associated diarrhea, QT prolongation (with clarithromycin), and potential for antibiotic resistance.
## Key Drug Interactions
* **Clarithromycin:** May increase serum concentrations of drugs metabolized by CYP3A4 (e.g., warfarin, certain statins, benzodiazepines).
* **Esomeprazole:** May decrease absorption of drugs requiring acidic gastric pH (e.g., ketoconazole, iron salts). May affect absorption of vitamin B12.
* **Amoxicillin:** May decrease the efficacy of oral contraceptives.
## Monitoring
* Monitor for signs and symptoms of allergic reactions.
* Monitor for signs and symptoms of *C. difficile*-associated diarrhea.
* Evaluate for H. pylori eradication after completion of therapy (e.g., urea breath test, stool antigen test).
## Clinical Pearls
* Administer the esomeprazole capsule whole, do not crush or chew.
* Administer amoxicillin and clarithromycin as directed to ensure adequate eradication rates.
* Patients should be advised to complete the full course of therapy, even if they feel better.
* Consider potential for antibiotic resistance in cases of treatment failure.
***
*This information is intended for clinical use and does not replace a thorough review of the most current prescribing information and relevant guidelines. Always verify current drug information and patient-specific factors before making therapeutic decisions.*
